Professional Documents
Culture Documents
DEVELOPMEN
T AGENCY
Digitally signed by
INFORMATICS
DEVELOPMENT AGENCY
Date: 2015.01.23 09:56:45
EET
Reason:
Location: Athens
: 73-
/
&
/
: .
. : 19
. : 101 87
:,2132161327
FAX: 210 5237384
Email: ddy@yyka.gov.gr
, 22/1/2015
. . 1/...6050
: & 2015
.: 6
&
.
.:
& 2015 11 -
1. , &
( )
29,, .. 10110
2. ...
( )
3.
/ & ( )
. /
4.
& ( )
/
( )
1
: 73-
5.
( )
6. ...
384 ,11522
7.
39, 15123
( )
1.
37, 15180
2. /
(
)
3. /
153, 118 54
4. & &
/
( )
40, 101 82
5.
3, 10675 -
( )
6.
( )
134, 118 54 -
7.
( )
38, , .. 10678
8.
. 196 . . 11521
9. ..
. 127 . . 11521
10. ....
3-5, 15121 M
11.
.
/
..115 27 -
12.
39,
13.
205,
, .. 11853
14. ...
. 34, 16672
2
: 73-
15. .
. .
& 1
1. .
2. .
3. .
4. . .
5. . . /
6. /
: 73-
()
HepB
1
(HepB)
HepB
1
,
,
(DTaP <7 ,
2
Tdap 7 )
3
b (Hib)
4
(IPV)
5
(PCV13)
5
/ (PPSV23)
6
(MCC, MCV4)
, ,
7
(MMR)
8
(VAR)
(HepA)
1. 2015*
1
2
4
6
12
15
18 19-23
2-3
HepB
HepB
HepB 3 4
HepB
HepB
DTaP
DTaP
Hib
Hib
IPV
IPV
PCV13
PCV13
HepB 3
DTaP
DTaP
Hib
Hib
PCV13
7-10
HepB
11-12
13-15
16-18
HepB
DTaP
DTaP
Hib
DTaP
TdapIPV
TdapIPV
Hib
IPV
IPV
PCV13
PCV13
Tdap-IPV
Hib
IPV
IPV
PCV13
PPSV23
MCC
1
MMR 1
MCC 1
MMR
VAR 1
10
(HPV)
11
( BCG)
12
13
(RV)
4-6
VAR
MMR
2
VAR
2
HepA
2
BCG
Mantoux
RV1 RV5
RV1 RV5
MCV4
1
MMR
MCV4 1
VAR
HepA
BCG
RV5
* . ,
( . )
HPV
2
BCG
HPV
3
: 73-
( 1)
1.
(HepB): ( : ).
HepB
(HbsAg +), 1
HepB, 0,5 ml , (HBIG),
12 .
HbsAg ,
1 HepB 12 .
(HBsAg)
HBIG
.
HepB 1
2
1-2
24 (6 ). 4
2000g.
-
3 HepB , 9-18 HBsAg
anti-HBs. Hep B
,
(anti-HBs 10mlU/ml).
HepB
3
HepB ( 0, 1, 6 ), 2
. 1 2 Hep B
4 1 3 4 .
,
.
24 (6 ).
2.
, , (DTaP) < 7 .
( : 6 ).
5 . 4
15 6 3
. 5 4-6 .
DTaP 4 DTaPIPV, 5- DTaP-IPV-ib 6- DTaP-IPVib-HepB.
.
-, (Tdap) 7
Tdap
DTaP.
,
(Tdap-IPV). 11-12 .
Tdap-IPV
: 73-
. Td 10-
.
3.
b (Hib). (
: 6 ).
4 .
4.
(IPV). ( : 6
)
4 IPV.
DTaP IPV,
3 4 DTaP -IPV DTaP-IPV- ib DTaP-IPVib- HepB ( 5 IPV).
4 4 ,
4-6 .
5.
(PCV13) ( : 6
)
(PPSV23) (
: 2 )
PCV13 2-59
.
2-6 3
PCV13 12-15
. 7-11 2
12-23 .
12-23 2 PCV13 2
, 24 PCV13.
23- (PPSV)
(PCV13) 2
PCV13, >2
( ).
PPSV23 5 1
.
C (CC)
A,C ,Y, W135 ( MCV4) (
MCC 6 MCV4 1 .
MCC 1 12 .
MCC 2 , (2, 4, 12 )
MCV4 11 .
>1 ,
MCC, 2
MCV4 2 5-.
MCC 1 MCV4
.
, , (MMR) ( : 12
)
2 . 2
4, ,
4 .
6.
7.
: 73-
8.
9.
10.
11.
12 .
2 4
18 .
1 MMR 6 11
,
. MMR
6 .
2 MMR
12 .
(VAR) ( : 12 )
12
. 2 4 ,
3
. 2
1 12 12
.
--- (MMRV) (
: 12 ).
MMRV MMR
, (1 12-15 2
4 ).
2-3 .
( HepA). ( : 12 )
6 12
.
(HPV) ( : 9 )
.
.
(HPV2) (HPV4) HPV.
HPV2 HPV4 2 6
( 0, 6) 11 <15 .
15 , 3
( 0, 1-2, 6 ). 2
6 3 6
.
( BCG).
(..
, ..)
.
, (
)
Mantoux 12-15
, 4 6 ( BCG) 11 12
(
).
: 73-
12.
13.
.
[
: IIV3 (nactivated Influenza Vaccine , IIV3),
TIV (Trivalent Inactivated Vaccine)] 0,5 ml.
> 6
(. )
3
.
.
6 8
.
( RV)
:
T (RV1), 2 (2 4 )
(RV5) 3 (2,4,6 ).
6 .
6 .
, 1
15
8 .
1 ,
RV1 RV5.
,
1.
, (>5 64 )
:
,
, ,
( IgG2)
,
HIV
: 73-
2.
3.
/
4.
5.
,
, HIV
( , )
( - )
Hajj
.
.
HIV
(
AIDS.
,
.
,
,
( )
, 60
. 2
2
.
: 73-
6.
,
,
HIV,
60 .
:
(
).
(
).
.
.
-
, ,
() >40 kg/m2
>95
(..
Kawasaki, )
Reye
<6
,
.
(
(, ,
..).
( )
(.. , )
11-12 ,
.
,
( ), .
2 3,
.
10
: 73-
2: 4 6
2015*
(HepB)
, ,
(DaP)
3
IPV
4
b (Hib)
1-2
2-3
4 1
4
4
1 <12
8 ( )
1 12-14
1
15
C (MCC)
A,C,W135,Y
5
(MCV4)
13
6
(PCV13)
, ,
7
(MMR)
8
(VAR)
9
(Hep)
11
12
3-4
4-5
4
<12
8
12 1 <12
2 <15
15
8 (
)
4
12-59
3
<12
12
12
4
1 <12
8 ( )
1 12
1
24
12
12
12
3
6
4 : <12
8 : ( )
7-11 ( 12
) 12
1 12
24
12 4-6
4 / ( 1 )
* (. )
11
8 (
)
4
12-59
3
<12
: 73-
3: 7-18
2015*
(HepB)
, (Td),
(Tdap)
IPV
C (MCC)
1-2
2-3
4 1
4
1 DTaP/DT
<12
6 ( )
1 12
6
1
DTaP/DT
<12
A,C,W135,Y
5
(MCV4)
12
, ,
7
(MMR)
12
(Hep)
10
(HPV)
12
12
9
4-8
12
3-4
(MCC) 1-10
11-18
2 12 8
3
13
4
13
6
(VAR)
4-5
* (. )
12
: 73-
(
2 3)
1.
(HepB)
Hep B 3
.
2.
, , (DTaP) < 7
-, (Tdap) 7
5 DTaP 4 4
. Tdap 11-12 ,
. (
1). Td 10 .
7-10 DTaP
Tdap
( Td).
Tdap .
11-18 Tdap
Td 10- .
7-10 , , DTaP ,
Tdap .
3.
(IPV). 3 IPV.
4.
b (Hib).
Hib 2 12 1
.
1,2 3 12
10 .
Hib, >5 ,
, 1 .
( , ,
, HIV ) 2
12 2 ,
8 .
13
: 73-
5.
C (CC)
A,C ,Y, W135 ( MCV4)
MCC 12 10 .
11 1 (MCV4).
(
, HIV , ),
MCC 2 3 (2, 4, 12 ).
> 12 , 2 MCV4
8 , MCC.
1
MCV4 12 11 .
6.
(PCV13)
(PPSV23)
7
4 PCV13 1 ( 4
15 ).
12 23 2
6-8
24 ,
.
PCV13
PPSV23.
2 5 2 PCV13, 8
, 3
PCV13 3 .
5
PCV13.
2
PPSV23 PCV13 8 2
PPSV23 5 1 PPSV23.
7.
, , (MMR)
2 MMR 4 .
, 2
4 .
8.
(VAR)
12
2 2 .
9.
( HepA).
HAV 6 12
.
10, 10.
11, 1
11.
1.
12.
14